• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society.

作者信息

Chung K F, Godard P, Adelroth E, Ayres J, Barnes N, Barnes P, Bel E, Burney P, Chanez P, Connett G, Corrigan C, de Blic J, Fabbri L, Holgate S T, Ind P, Joos G, Kerstjens H, Leuenberger P, Lofdahl C G, McKenzie S, Magnussen H, Postma D, Saetta M, Salmeron S, Sterk P

机构信息

National Heart & Lung Institute, Imperial College School of Medicine, London, UK.

出版信息

Eur Respir J. 1999 May;13(5):1198-208. doi: 10.1034/j.1399-3003.1999.13e43.x.

DOI:10.1034/j.1399-3003.1999.13e43.x
PMID:10414427
Abstract
摘要

相似文献

1
Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society.
Eur Respir J. 1999 May;13(5):1198-208. doi: 10.1034/j.1399-3003.1999.13e43.x.
2
Treatment of asthma.
J Fla Med Assoc. 1996 Jun-Jul;83(6):384-8.
3
Severe Asthma: Challenges and Pitfalls in Management.重度哮喘：管理中的挑战与陷阱
Indian J Pediatr. 2018 Sep;85(9):763-772. doi: 10.1007/s12098-018-2686-0. Epub 2018 May 7.
4
Asthma in 2016: reassured about the old, excited about the new.2016年的哮喘：对旧有情况放心，对新情况激动。
Lancet Respir Med. 2016 Dec;4(12):937-939. doi: 10.1016/S2213-2600(16)30380-0. Epub 2016 Nov 22.
5
[Severe Asthma].[重度哮喘]
Dtsch Med Wochenschr. 2015 Oct;140(20):1524-8. doi: 10.1055/s-0041-105706. Epub 2015 Oct 7.
6
Traditional Therapies for Severe Asthma.重度哮喘的传统疗法
Immunol Allergy Clin North Am. 2016 Aug;36(3):581-608. doi: 10.1016/j.iac.2016.03.013.
7
[Control of inhaled triggering factors decreases prolonged drug therapy requirements in patients with asthma].
Invest Clin. 2000 Mar;41(1):3-18.
8
[Diagnostics and therapy of asthma].[哮喘的诊断与治疗]
Duodecim. 2000;116(22):2568-84.
9
[The implementation gap in asthma prevention and control?].[哮喘预防与控制中的实施差距？]
Bull Acad Natl Med. 2014 Apr-May;198(4-5):745-55; discussion 755-6.
10
The management of chronic asthma in childhood.儿童慢性哮喘的管理
Ir Med J. 1995 Jan-Feb;88(1):10, 9.

引用本文的文献

1
Using Lung Ultrasound Combined With N-terminal Pro-brain Natriuretic Peptide to Differentiate Acute Heart Failure From Chronic Obstructive Pulmonary Disease and Asthma in Emergency Department Patients Experiencing Acute Shortness of Breath.在急诊科急性呼吸急促的患者中，使用肺部超声联合N末端脑钠肽前体来鉴别急性心力衰竭与慢性阻塞性肺疾病和哮喘
Cureus. 2025 Jan 9;17(1):e77171. doi: 10.7759/cureus.77171. eCollection 2025 Jan.
2
Rare/Common Variants Are Associated with Inhaled Corticosteroid Response among Children with Asthma.罕见/常见变异与哮喘儿童吸入性糖皮质激素反应相关。
Genes (Basel). 2024 Mar 28;15(4):420. doi: 10.3390/genes15040420.
3
PI3Kγδ inhibition suppresses key disease features in a rat model of asthma.
PI3Kγδ抑制可抑制哮喘大鼠模型的关键疾病特征。
Respir Res. 2024 Apr 23;25(1):175. doi: 10.1186/s12931-024-02814-1.
4
Progress in diagnosis and treatment of difficult-to-treat asthma in children.儿童难治性哮喘的诊治进展。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231213637. doi: 10.1177/17534666231213637.
5
Severe pediatric asthma therapy: Omalizumab-A systematic review and meta-analysis of efficacy and safety profile.重度小儿哮喘治疗：奥马珠单抗——疗效与安全性概况的系统评价和荟萃分析
Front Pediatr. 2023 Mar 3;10:1033511. doi: 10.3389/fped.2022.1033511. eCollection 2022.
6
Paroxysmal dyspnoea in asthma: Wheeze, ILO or dysfunctional breathing?哮喘中的阵发性呼吸困难：哮鸣、间质性肺病还是功能性呼吸障碍？
Front Allergy. 2022 Nov 17;3:1054791. doi: 10.3389/falgy.2022.1054791. eCollection 2022.
7
Asthma Exacerbations and Glucagon-Like Peptide-1 Receptor Agonists: a Review of the Current Evidence.哮喘急性加重与胰高血糖素样肽-1受体激动剂：当前证据综述
Pulm Ther. 2022 Dec;8(4):343-358. doi: 10.1007/s41030-022-00203-x. Epub 2022 Nov 22.
8
Does the Use of Asthma-Controller Medication in Accordance with Guidelines Reduce the Incidence of Acute Exacerbations and Healthcare Costs?按照指南使用哮喘控制药物是否能降低急性加重的发生率和医疗费用？
Tuberc Respir Dis (Seoul). 2022 Jan;85(1):11-17. doi: 10.4046/trd.2021.0087. Epub 2021 Sep 3.
9
T17 cells and corticosteroid insensitivity in severe asthma.严重哮喘中的 T17 细胞和皮质类固醇不敏感性。
J Allergy Clin Immunol. 2022 Feb;149(2):467-479. doi: 10.1016/j.jaci.2021.12.769. Epub 2021 Dec 23.
10
Leukotriene B Receptors Are Necessary for the Stimulation of NLRP3 Inflammasome and IL-1β Synthesis in Neutrophil-Dominant Asthmatic Airway Inflammation.白三烯B受体对于中性粒细胞为主的哮喘气道炎症中NLRP3炎性小体的激活及白细胞介素-1β的合成是必需的。
Biomedicines. 2021 May 11;9(5):535. doi: 10.3390/biomedicines9050535.